tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Technical Analysis

512 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cue Biopharma Inc’s (CUE) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Cue Biopharma Inc is a Buy.
Cue Biopharma Inc’s (CUE) 20-Day exponential moving average is 1.38, while Cue Biopharma Inc’s (CUE) share price is $1.08, making it a Sell.
Cue Biopharma Inc’s (CUE) 50-Day exponential moving average is 1.56, while Cue Biopharma Inc’s (CUE) share price is $1.08, making it a Sell.

Cue Biopharma (CUE) Pivot Points

Jul 03, 2024, 03:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.52
0.73
0.87
1.08
1.23
1.44
1.58
Fibonacci
0.73
0.86
0.95
1.08
1.22
1.30
1.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cue Biopharma (CUE) Moving Averages

Jul 03, 2024, 03:59 AM
Period
Simple
Exponential
MA5
1.22Sell
1.19Sell
MA10
1.30Sell
1.27Sell
MA20
1.40Sell
1.38Sell
MA50
1.59Sell
1.56Sell
MA100
1.78Sell
1.80Sell
MA200
2.13Sell
2.19Sell
Cue Biopharma Inc’s (CUE) 10-Day exponential moving average is 1.27, while Cue Biopharma Inc’s (CUE) share price is $1.08, making it a Sell.
Cue Biopharma Inc’s (CUE) 100-Day exponential moving average is 1.80, while Cue Biopharma Inc’s (CUE) share price is $1.08, making it a Sell.
Cue Biopharma Inc’s (CUE) stock price is $1.08 and Cue Biopharma Inc’s (CUE) 50-day simple moving average is 1.59, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $1.08 and Cue Biopharma Inc’s (CUE) 100-day simple moving average is 1.78, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $1.08 and Cue Biopharma Inc’s (CUE) 200-day simple moving average is 2.13, creating a Sell signal.

Cue Biopharma (CUE) Technical Indicators

Jul 03, 2024, 03:59 AM
Name
Value
Implied Action
RSI (14)
32.73
Neutral
STOCH (9,6)
11.72
Buy
STOCHRSI (14)
10.57
Buy
MACD (12,26)
-0.13
Buy
ADX (14)
15.21
Buy
Williams %R
-79.94
Buy
CCI (14)
-205.43
Buy
ATR (14)
0.17
-
Ultimate Oscillator
31.33
Neutral
ROC
-26.53
Sell
Cue Biopharma Inc’s (CUE) Relative Strength Index (RSI) is 32.73, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Trend Strength Indicator (ADX) is 15.21, creating a Buy signal.
Cue Biopharma Inc’s (CUE) Commodity Channel Index (CCI) is -205.43, creating a Buy signal.
Cue Biopharma Inc’s (CUE) Price Rate of Change (ROC) is -26.53, creating a Sell signal.

FAQ

Is CUE a Buy, Hold, or Sell?
Based on CUE’s technical indicators, CUE is a Sell.
    What is CUE’s RSI (14)?
    CUE’s RSI (14) is 32.73, which suggests CUE is a Neutral.
      What is CUE’s MACD?
      CUE’s MACD is -0.13, which suggests CUE is a Buy.
        What is CUE’s 5-day moving average?
        CUE’s 5-day moving average is 1.22, which suggests CUE is a Sell.
          What is CUE’s 20-day moving average?
          CUE 20-day moving average is 1.40, which suggests CUE is a Sell.
            What is CUE’s 50-day moving average?
            CUE’s 50-day moving average is 1.59, which suggests CUE is a Sell.
              What is CUE’s 200-day moving average?
              CUE’s 200-day moving average is 2.13, which suggests CUE is a Sell.
                What is CUE’s Williams % R (14)?
                CUE’s Williams % R (14) is -79.94, which suggests CUE is a Buy.
                  What is CUE’s CCI (14)?
                  CUE’s CCI (14) is -205.43, which suggests CUE is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis